A key role for transketolase-like 1 in tumor metabolic reprogramming

• Published in: Oncotarget Vol. 7; no. 32; pp. 51875 - 51897
• Main Authors: Diaz-Moralli, Santiago, Aguilar, Esther, Marin, Silvia, Coy, Johannes F., Dewerchin, Mieke, Antoniewicz, Maciek R., Meca-Cortés, Oscar, Notebaert, Leen, Ghesquière, Bart, Eelen, Guy, Thomson, Timothy M., Carmeliet, Peter, Cascante, Marta
• Format: Journal Article
• Language: English
• Published: United States Impact Journals LLC 09.08.2016
• Subjects: Cell Line, Tumor; Glycolysis; Humans; Metabolome; Neoplasms - metabolism; Research Paper; Transketolase - metabolism; transketolase-like 1; metabolic reprogramming; pentose phosphate pathway; tumor metabolism; lipid metabolism
• ISSN: 1949-2553; 1949-2553
• DOI: 10.18632/oncotarget.10429

Metabolic reprogramming, a crucial cancer hallmark, shifts metabolic pathways such as glycolysis, tricarboxylic acid cycle or lipogenesis, to enable the growth characteristics of cancer cells. Here, we provide evidence that transketolase-like 1 (TKTL1) orchestrates aerobic glycolysis, fatty acid and nucleic acid synthesis, glutamine metabolism, protection against oxidative stress and cell proliferation. Furthermore, silencing of TKTL1 reduced the levels of sphingolipids such as lactosylceramide (a sphingolipid regulating cell survival, proliferation and angiogenesis) and phosphatidylinositol (which activates PI3K/Akt/mTOR signaling). Thus, in addition to its well-known roles in glucose and amino acid metabolism, TKTL1 also regulates lipid metabolism. In conclusion, our study provides unprecedented evidence that TKTL1 plays central roles in major metabolic processes subject to reprogramming in cancer cells and thus identifies TKTL1 as a promising target for new anti-cancer therapies.